HNP Capital’s Novartis NVS Stock Holding History

HNP Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,947	Closed	-$348K	–	235
2020 Q1	$348K	Buy	+3,947	New	+$352K	0.05%	182

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

HNP Capital's NVS Position: Q2 2020 in Review

HNP Capital sold out of Novartis (NVS) in Q2 2020, closing a stake of 3,947 shares — an estimated $348K sold.

HNP Capital first reported a position in NVS in Q1 2020 and held it in 1 quarter. The position peaked at $348K in Q1 2020. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

HNP Capital reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
HNP Capital sold 3,947 Novartis shares in Q2 2020, an estimated $348K.
HNP Capital first reported a position in Novartis in Q1 2020 and held it in 1 quarter.
HNP Capital's Novartis position peaked at $348K in Q1 2020.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on HNP Capital's 13F filing for Q2 2020, filed 6 Jul 2020.